title: Cerebrovascular incidents differ in patients with permanent and paroxysmal atrial fibrillation.
authors.affiliation: Neurological Department, Military Medical Institute, Szaserow, Warsaw, Poland. staszej@amwaw.edu.pl
authors.forename: Jacek
authors.initials: J
authors.lastname: Staszewski
authors.forename: Marzena
authors.initials: M
authors.lastname: Staszewska
authors.forename: Jerzy
authors.initials: J
authors.lastname: Kotowicz
authors.forename: Bogdan
authors.initials: B
authors.lastname: Brodacki
authors.forename: Kazimierz
authors.initials: K
authors.lastname: Tomczykiewicz
authors.forename: Adam
authors.initials: A
authors.lastname: Stepien
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D020520:Brain Infarction / Q000209:etiology / Q000401:mortality; D005069:Evaluation Studies as Topic; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000209:etiology / Q000401:mortality; D020766:Intracranial Embolism / Q000209:etiology / Q000401:mortality; D020767:Intracranial Thrombosis / Q000209:etiology / Q000401:mortality; D002546:Ischemic Attack, Transient / Q000209:etiology / Q000401:mortality; D008297:Male; D011044:Poland; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000209:etiology* / Q000401:mortality* / Q000517:prevention & control; D013614:Tachycardia, Paroxysmal / Q000150:complications* / Q000188:drug therapy
chemical_list: D000925:Anticoagulants